Hannah Wentzel
Reading, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Uncertainties in evaluating the health-related quality of life and disease burden of people with rare diseases and their caregivers in NICE HST submissions.
Journal: Orphanet journal of rare diseases
Published: March 21, 2024
Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Journal: Open forum infectious diseases
Published: February 11, 2022
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
Journal: The Journal of antimicrobial chemotherapy
Published: August 20, 2021
RETRACTED: Expression of Concern: "Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection".
Journal: Open forum infectious diseases
Published: August 19, 2021
Erratum Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
Journal: The Journal of antimicrobial chemotherapy
Published: March 11, 2021
Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection.
Journal: Open forum infectious diseases
Published: January 20, 2021
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
Journal: The Journal of antimicrobial chemotherapy
Published: August 24, 2020
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis.
Journal: The Journal of antimicrobial chemotherapy
Published: June 12, 2020
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19.
Journal: The Journal of antimicrobial chemotherapy
Published: June 03, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.
Journal: The Journal of antimicrobial chemotherapy
Published: June 02, 2020
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
Journal: The Journal of antimicrobial chemotherapy
Published: May 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026